217 related articles for article (PubMed ID: 30182170)
21. Clinico-radiological profile, management and follow-up of methotrexate induced neurotoxicity in children with acute lymphoblastic leukemia.
Dhariwal N; Roy Moulik N; Smriti V; Dhamne C; Chichra A; Srinivasan S; Narula G; Banavali S
Leuk Lymphoma; 2023 Dec; 64(12):1971-1980. PubMed ID: 37565568
[TBL] [Abstract][Full Text] [Related]
22. [Case of methotrexate encephalopathy: findings on diffusion tensor image and correlation with clinical outcome].
Terasawa Y; Nakane S; Ohnishi T; Harada M; Furutani K; Izumi Y; Kaji R
Rinsho Shinkeigaku; 2007; 47(2-3):79-84. PubMed ID: 17511273
[TBL] [Abstract][Full Text] [Related]
23. A woman who couldn't speak: report of methotrexate neurotoxicity.
Szawarski P; Chapman CS
Postgrad Med J; 2005 Mar; 81(953):194-5. PubMed ID: 15749798
[TBL] [Abstract][Full Text] [Related]
24. Ethnic-specific predictors of neurotoxicity among patients with pediatric acute lymphoblastic leukemia after high-dose methotrexate.
Harris RD; Bernhardt MB; Zobeck MC; Taylor OA; Gramatges MM; Schafer ES; Lupo PJ; Rabin KR; Scheurer ME; Brown AL
Cancer; 2023 Apr; 129(8):1287-1294. PubMed ID: 36692972
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate-Induced Subacute Neurotoxicity Surrounding an Ommaya Reservoir in a Patient with Lymphoma.
Oarbeascoa G; Rodriguez-Macias G; Guzman-de-Villoria JA; Fernandez-Garcia P; Churruca J; Diez-Martin JL; Bastos-Oreiro M
Am J Case Rep; 2019 Jul; 20():1002-1005. PubMed ID: 31295228
[TBL] [Abstract][Full Text] [Related]
26. Magnetization transfer imaging provides no evidence of demyelination in methotrexate-induced encephalopathy.
Miese FR; Schuster FR; Pierstorff K; Karenfort M; Laws HJ; Borkhardt A; Saleh A
AJNR Am J Neuroradiol; 2011; 32(6):E110-2. PubMed ID: 20651019
[TBL] [Abstract][Full Text] [Related]
27. Neurotoxicity of intrathecal methotrexate: MR imaging findings.
Sandoval C; Kutscher M; Jayabose S; Tenner M
AJNR Am J Neuroradiol; 2003 Oct; 24(9):1887-90. PubMed ID: 14561622
[TBL] [Abstract][Full Text] [Related]
28. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.
Ziereisen F; Dan B; Azzi N; Ferster A; Damry N; Christophe C
Pediatr Radiol; 2006 Mar; 36(3):205-12. PubMed ID: 16369780
[TBL] [Abstract][Full Text] [Related]
29. Alternating hemiparesis and orolingual apraxia as manifestations of methotrexate neurotoxicity in a paediatric case of acute lymphoblastic leukaemia.
Yap SM; MacEneaney P; Ryan C; O'Toole O
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27113788
[TBL] [Abstract][Full Text] [Related]
30. Subacute methotrexate neurotoxicity in patients with oncohematological disease. A report of 3 cases.
Delgado EF; Ruggeri RA; Calvo C
Arch Argent Pediatr; 2023 Apr; 121(2):e202202649. PubMed ID: 36378235
[TBL] [Abstract][Full Text] [Related]
31. [Hemiparesis and facial palsy caused by methotrexate].
Rueda Arenas E; García Corzo J; Franco Ospina L
An Pediatr (Barc); 2013 Dec; 79(6):385-9. PubMed ID: 23786802
[TBL] [Abstract][Full Text] [Related]
32. Biochemical and clinical aspects of methotrexate neurotoxicity.
Vezmar S; Becker A; Bode U; Jaehde U
Chemotherapy; 2003 May; 49(1-2):92-104. PubMed ID: 12714818
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and management of methotrexate-induced neurotoxicity in pediatric patients with osteosarcoma: a single-center experience.
Peled Y; Levin D; Shiran S; Manisterski M; Shukrun R; Elhasid R
Int J Clin Oncol; 2022 Aug; 27(8):1372-1378. PubMed ID: 35639227
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate-induced toxic leukoencephalopathy: an uncommon stroke mimic.
Maas RPPWM; Pegge SAH; Evers D; van Samkar A; Klijn CJM
Neurol Sci; 2019 Jun; 40(6):1307-1309. PubMed ID: 30637582
[No Abstract] [Full Text] [Related]
35. Correlating pathology with the clinical symptoms of methotrexate-induced leukoencephalopathy in a child with relapsed T-cell acute lymphoblastic leukemia.
Summers RJ; Abramowsky CR; Cooper TM
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e19-22. PubMed ID: 23274378
[TBL] [Abstract][Full Text] [Related]
36. Acute methotrexate neurotoxicity revealed by a cerebellar syndrome.
Zahra K; Bouneb R; Mahjoub M; Zaghouani H; Zaier M; Ben Youssef Y; Khelif A
Rev Neurol (Paris); 2016 Dec; 172(12):791-793. PubMed ID: 27773447
[No Abstract] [Full Text] [Related]
37. Severe, Fatal Methotrexate-related Neurotoxicity in 2 Adolescent Patients With ALL.
Dabagh S; David H; Young S; Doan A; Bhojwani D
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e839-e844. PubMed ID: 31876782
[TBL] [Abstract][Full Text] [Related]
38. Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate.
Eichler AF; Batchelor TT; Henson JW
Neuro Oncol; 2007 Jul; 9(3):373-7. PubMed ID: 17522329
[TBL] [Abstract][Full Text] [Related]
39. Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.
Cohen IJ
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1057-1065. PubMed ID: 28455583
[TBL] [Abstract][Full Text] [Related]
40. Subacute methotrexate-related leukoencephalopathy with stroke-like presentation.
Iwatani K; Fujii N; Deguchi S; Tanimoto M
Int J Hematol; 2012 Dec; 96(6):683-4. PubMed ID: 23114968
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
